Drug Trial Radar · NCT05897424
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
Last checked: Nov 19, 2026Latest source record: Apr 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
185
Planned (sponsor's estimate)
Start
Jun 20, 2024
Primary completion
Jun 30, 2028
Study completion Sep 30, 2028
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jun 9, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 2 open label extension study to evaluate SAR447537 (INBRX-101) in adults with AATD emphysema
Conditions
- Alpha 1-Antitrypsin Deficiency
- Emphysema
Interventions
SAR447537Drug
A1PI, Recombinant, Bivalent Fc Fusion Protein
Primary outcomes
What the sponsor says the trial is designed to measure.
- Long-term safety and tolerabilityTime frame: 3 years
Locations
40 sites in 9 countries. Site status is shown where the registry gives one.
UAB Lung Health Center- Site Number : 105
Birmingham, Alabama
St Joseph's Hospital and Medical Center- Site Number : 126
Phoenix, Arizona
David Geffen School of Medicine at UCLA- Site Number : 124
Los Angeles, California
University of California Davis Medical Center- Site Number : 110
Sacramento, California
National Jewish Medical and Research Center- Site Number : 123
Denver, Colorado
Nuvance Health Medical Practices, Pulmonary & Sleep Specialists- Site Number : 119
Danbury, Connecticut
University of Florida - Gainesville - 1600 SW Archer Rd- Site Number : 101
Gainesville, Florida
Indiana University- Site Number : 127
Indianapolis, Indiana
Brigham and Women's Hospital -75 Francis Street- Site Number : 131
Boston, Massachusetts
University of Minnesota-420 Delaware Str SE- Site Number : 125
Minneapolis, Minnesota
Hannibal Regional Healthcare System-HRMG-Hannibal- Site Number : 111
Hannibal, Missouri
Columbia University Irving Medical Center- Site Number : 104
New York, New York
Oregon Health and Science University- Site Number : 117
Portland, Oregon
Penn State Health Milton S. Hershey Medical Center- Site Number : 122
Hershey, Pennsylvania
Temple University Hospital - 3401 N Broad St- Site Number : 130
Philadelphia, Pennsylvania
Velocity Clinical Research - Spartanburg - PPDS- Site Number : 120
Spartanburg, South Carolina
Houston Methodist Hospital- Site Number : 113
Houston, Texas
University of Utah Health Care- Site Number : 106
Salt Lake City, Utah
Investigational Site Number : 202
Chermside, Queensland, Australia
Investigational Site Number : 204
South Brisbane, Queensland, Australia
Investigational Site Number : 201
North Adelaide, South Australia, Australia
Investigational Site Number : 207
Box Hill, Victoria, Australia
Investigational Site Number : 203
Fitzroy, Victoria, Australia
Investigational Site Number : 205
Frankston, Victoria, Australia
Investigational Site Number : 701
Hellerup, Denmark
Investigational Site Number : 702
Vejle, Denmark
Investigational Site Number : 501
Dublin, Dublin, Ireland
Investigational Site Number : 403
Auckland, New Zealand
Investigational Site Number : 404
Wellington, New Zealand
Investigational Site Number : 802
Krakow, Poland
Investigational Site Number : 801
Warsaw, Masovian Voivodeship, Poland
Investigational Site Number : 902
Madrid, Spain
Investigational Site Number : 903
Santiago de Compostela, Spain
Investigational Site Number : 901
Santander, Cantabria, Spain
Investigational Site Number : 601
Gothenburg, Sweden
Investigational Site Number : 309
Coventry, United Kingdom
Investigational Site Number : 308
Dundee, Angus, United Kingdom
Investigational Site Number : 306
Wythenshawe, Cheshire, United Kingdom
Investigational Site Number : 307
Exeter, Devon, United Kingdom
Investigational Site Number : 304
Southampton, Hampshire, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.